C. Yao

发表

Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study

Z. Hong, Yan Cheng, E. Xu, 2008, The Lancet Neurology.

The effect of thyroxine‐suppressive therapy in patients with solitary non‐toxic thyroid nodules – a randomised, double‐blind, placebo‐controlled study

Y. Hung, M. Hsieh, D. Pei, 2005, International journal of clinical practice.

Infliximab versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a preliminary study from China

C. Bao, Dong-hai Wu, Fengchun Zhang, 2006 .

Comparing an internet-based medical model with a conventional medical model in the management of patients with hypertension in China: Methodology of a cluster randomized study

Jianping Li, Bei Shi, Dong Zhao, 2018 .

[Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients].

Qinghua Zhou, Yiping Zhang, Z. Guan, 2005, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[Randomized phase II trial on escalated doses of Rh-endostatin (YH-16) for advanced non-small cell lung cancer].

Pei-wen Li, L. Di, Yan Sun, 2006, Zhonghua zhong liu za zhi [Chinese journal of oncology].

First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study

B. Han, K. Li, P. Yu, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Results of phase III trial of rh-endostatin (YH-16) in advanced non-small cell lung cancer (NSCLC) patients

Xingzhi Song, Youzhong Zhang, Yan Sun, 2005 .

Optimal Dosage of Botulinum Toxin Type A for Treatment of Glabellar Frown Lines: Efficacy and Safety in a Clinical Trial

Jinhua Xu, Zheng Feng, C. Yao, 2015, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: a multicenter double-blinded randomized controlled trial.

Ping Li, Wei Sun, Jing Li, 2012, Journal of ethnopharmacology.

Effects of sibutramine in overweight, poorly controlled Chinese female type 2 diabetic patients: a randomised, double‐blind, placebo‐controlled study

M. Hsieh, D. Pei, S. Kuo, 2005, International journal of clinical practice.

Long‐term results of a randomized, double‐blind, and placebo‐controlled phase III trial: Endostar (rh‐endostatin) versus placebo in combination with vinorelbine and cisplatin in advanced non‐small cell lung cancer

Qiang Chen, Wei Liu, Yan Sun, 2013, Thoracic cancer.

A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure.

W. Yao, Xinli Li, A. Ma, 2013, Journal of the American College of Cardiology.

Serum low-density lipoprotein and heart rate related to the effectiveness in the treatment of angina pectoris with two similar Chinese medicine herbal formulae

A. Lu, M. Jiang, C. Yao, 2011, Chinese journal of integrative medicine.

Effect of orlistat in overweight poorly controlled Chinese female type 2 diabetic patients: a randomised, double‐blind, placebo‐controlled study

M. Hsieh, D. Pei, S. Kuo, 2006, International journal of clinical practice.

First-line icotinib versus cisplatine/pemetrexed plus pemetrexed maintenance therapy in lung adenocarcinoma patients with sensitizing EGFR mutation (CONVINCE).

B. Han, He-long Zhang, Yunpeng Liu, 2016 .

A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure.

W. Yao, Xinli Li, A. Ma, 2013, Journal of the American College of Cardiology.